Showing results (1441-1450 of 2,506) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|February 22, 2020
Time course of metabolic status in pregnant women: The Japan Environment and Children's StudyHatoko Sasaki, Naoko Arata, Ai Tomotaki, et al.Journal of Diabetes Investigation|December 12, 2018
Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysisXiao-Dong Geng, Wei-Wei Wang, Zhe Feng, et al.Journal of Diabetes Investigation|August 15, 2017
Lipopolysaccharide inhibits hepatic gluconeogenesis in rats: The role of immune cellsHiroshi Tanaka, Yoshikazu Nishikawa, Toru Fukushima, et al.Journal of Diabetes Investigation|March 24, 2018
Human pancreatic α- to β-cell area ratio increases after type 2 diabetes onsetYukari Fujita, Junji Kozawa, Hiromi Iwahashi, et al.Journal of Diabetes Investigation|March 26, 2018
Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation ProgramLinsey Gani, Eric Lau, Andrea Luk, et al.Journal of Diabetes Investigation|March 26, 2018
(Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapyAtsuhiro Kanda, Susumu IshidaJournal of Diabetes Investigation|March 26, 2018
Lactation and progression to type 2 diabetes in patients with gestational diabetes mellitus: A systematic review and meta-analysis of cohort studiesLijun Feng, Qunli Xu, Zhefang Hu, et al.Journal of Diabetes Investigation|November 3, 2019
Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directionsTatsuhito Himeno, Hideki Kamiya, Jiro NakamuraJournal of Diabetes Investigation|October 29, 2017
Curcumin attenuates high glucose-induced inflammatory injury through the reactive oxygen species-phosphoinositide 3-kinase/protein kinase B-nuclear factor-κB signaling pathway in rat thoracic aorta endothelial cellsZhen Zhang, Keming LiJournal of Diabetes Investigation|August 25, 2017
Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory studyNobuya Inagaki, Hiroki Sano, Yoshifumi Seki, et al.Pageof 251